Skip to main content

Table 1 Sequential change of CP amounts attached to inside of stocked vials

From: Prevention of the exposure by cyclophosphamide oral tablet

    Stored periods
    Day 7 Day 14 Day 28 Day 56
Amount of CPa
(ng/vial)
Vehicle RTb ND ND ND ND
4 °C ND ND ND ND
Endoxan® tablets RT 8.0 ± 1.2 10.3 ± 2.7 17.2 ± 2.0* 49.0 ± 6.7**
4 °C ND <3 <3 6.0 ± 1.0##
  1. a) cyclophosphamide
  2. b) room temperature
  3. Data are represented by mean ± SD. * p < 0.05; ** p < 0.01, Dunnet’s multiple comparison test; ## p < 0.01, unpaired t-test; ND; not detected, < 3; under the detection limit (3 ng/vial)